Search This Blog

Wednesday, August 7, 2019

Aerie Pharmaceuticals EPS beats by $0.08, beats on revenue

Aerie Pharmaceuticals (NASDAQ:AERI): Q2 Non-GAAP EPS of -$0.80 beats by $0.08; GAAP EPS of -$1.04 misses by $0.05.
Revenue of $15.84M (+554.5% Y/Y) beats by $0.88M.
Shares -10.56%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)